glp-1 cardiovascular outcomes 2025 news The Many Benefits of Drugs The cardiovascular effects of GLP-1

Proglucagon is stored in intracellular granules where it undergoes post-translational processing and is cleaved by prohormone convertase 1/3 to produce peptides such as GLP-1 (Orskov et al., 1986)

Exenatide (Byetta and Bydureon) Exenatide is currently marketed in two primary formulations: Byetta and Bydureon, representing the immediate-release and extended-release forms, respectively

Hold for a minimum of 2 minutes, though 3-5 minutes produces significantly better absorption

Younger participants (1849 years) exhibited a higher risk of suicidal ideations or attempts (3.01, 95% CI: 2.703.37), while older participants ( 70 years) had a lower overall risk of psychiatric diseases (1.71, 95% CI: 1.611.82)

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial